China-based MicroPort Scientific Corp’s (HKG: 0853) spin-off MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160) announced that it has received marketing approval in Colombia for its second-generation transcatheter aortic valve implantation (TAVI) products, the VitaFlow Liberty transcatheter aortic valve implantation system and the first-generation tip pre-shaped super-stiff guide wire Angelguide.
Product Details
VitaFlow Liberty features a unique innovative double-rib helical structure, which ensures fast, stable, and precise release and recovery. It also provides excellent passing performance and 360-degree bending of the valve segment. Angelguide is characterized by high guide wire support and smooth transitions, which help reduce vascular damage and improve release accuracy.
Global Approvals
VitaFlow Liberty was approved in China in August 2021. It obtained market approval in Argentina in December 2021, the same time that a CE mark filing was made with the European Union.-Fineline Info & Tech
